CompletedNot Applicable

Conduction System Pacing With INGEVITY+

United States1,383 participantsStarted 2023-11-13

Plain-language summary

The study is intended to evaluate the safety and effectiveness of the Boston Scientific INGEVITY+ cardiac pacing lead when implanted in the left bundle branch area (LBBA).

Who can participate

Age range1 Day

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕ICD and CRT-D devices

What they're measuring

Lead-Related Complication Free Rate

Timeframe: Implant through 90 days

Pacing Threshold

Timeframe: Implant through 90 days

Sensed R-wave amplitude

Timeframe: Implant through 90 days

Trial details

NCT IDNCT06014866

SponsorDuke University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-27

View on ClinicalTrials.gov More Bradycardia trials